Jeff Bezos has had quite a hectic week, having just concluded his third venture capital investment in a promising artificial intelligence startup. This time, the recipient of Bezos’s largesse is a ...

Jefferies London Healthcare Conference 2025 November 20, 2025 7:30 AM ESTCompany ParticipantsJames Hippel - Executive VP ...

IS the big Christmas countdown even happening if you don’t have an Advent calendar? Looking at the options available this ...

YETI’s global expansion, product innovation, and strong partnerships make it a smart long-term investment. Read here for more ...

From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...

RBC Capital analyst Leonid Timashev upgraded Design Therapeutics (DSGN) to Outperform from Sector Perform with a price target of $13, up from $6.

Design Therapeutics (DSGN) added ~15% on Thursday after RBC Capital Markets upgraded the stock to Outperform from Sector Perform, citing a catalyst-rich period for the small molecule drug developer in ...

Related: The Mozzarella Sticks At This Diner in Ohio Are So Good, You’ll Wish You Lived Next Door Related: The Underrated Historic Town In Ohio That’s Made For A Stress-Free Day Trip Sharp cheddar ...

As we age, the composition and function of proteins in the brain change, affecting how well our brain performs later in ...

Moms are overstimulated, exhausted and over it. These calming gifts for women are the holiday gift-giving antidote.